isi Halaman
Citius Prescribed drugs, Inc. Stories Fiscal Complete 12 months 2022 Monetary Effects and Supplies Industry Replace

Citius Prescribed drugs, Inc. Stories Fiscal Complete 12 months 2022 Monetary Effects and Supplies Industry Replace

$41.7 million in money and money equivalents as of September 30, 2022; extends runway via December 2023 Mino-Lok® Section 3 trial nearer to of completion with 169 sufferers recruited, 72 failure occasions and 17 sufferers in lively remedy or pending knowledge evaluation I/ONTAK BLA accredited for submitting through the FDA; up to date PDUFA goal…

Read More